Protein Production
293FT, 293E, CHO

Truly Functional Protein
95% Purity
1-10 mg in 2 weeks

GeneExpressoMax™
293Expresso™

Transfection Reagents
* 90% Efficiency
* 95% Viability
* No sera interference
* Simple protocol
* High-throughput
* Only $98/ml

Baculovirus
Functional Protein
95% Purity
Fast turnaround
1-10 mg from Sf9 cells

Adenovirus, AAV
& Lentivirus

ORF or shRNA
* High Titer
* Cre, FLP, ΦC31
* Protein Kinases
* Transcription Factors
* Luciferases, GFP, RFP
* Protein Production
* Stable Cell Line


Excellgen

Bibo Li
Cleveland State University

Project start date: 2005-07-01

Project end date: 2016-01-31


Sponsored Links Excellgen http://Excellgen.com

Baculovirus Protein Expression
Fast turn around, >95% purity functional protein. No outsourcing to China or India. $5500, $3950
Transient Protein Expression in CHO and HEK293 Cells
Transient Expression, Truly Functional Protein, 95% purity, 1~20 mg, fast turnaround. $5500, $3950
Recombinant Lentivirus & Adenovirus
High Yield and High Titer up to 1010 (lentivirus) and 1013 (adenovirus) for Guaranteed Expression of GOI. $3000, $2500

CHARACTERIZATION OF TRYPANOSOME TELOMERE COMPLEX

Bibo Li
Cleveland State University, Sponsored Programs And Research, Cleveland, Oh 44115

Grant 5R01AI066095-04 from National Institute Of Allergy And Infectious Diseases

Keywords: Africa South of the Sahara; African Sleeping Sickness; African Trypanosomiasis; Alleles; Allelomorphs; Antigen Variation; Antigenic Variability; Antigenic Variation; Binding; Binding (Molecular Function); Bovine Species; Cattle; Cell Line; Cell Lines, Strains; Cell Surface Glycoproteins; CellLine; Cells; Chromosomes; Cloning; Co-Immunoprecipitations; Complex; Gene Transcription; Genetic Alteration; Genetic Change; Genetic Transcription; Genetic defect; Genetics-Mutagenesis; Goals; Human; Human, General; Hybrids; Immune system; Knock-in; Knock-in Mouse; Knock-out; Knockout; Man (Taxonomy); Man, Modern; Mass Spectrum; Mass Spectrum Analysis; Membrane Glycoproteins; Moab, Clinical Treatment; Molecular Biology, Mutagenesis; Molecular Interaction; Monoclonal Antibodies; Mutagenesis; Mutation; Parasites; Pathogenesis; Phenotype; Photometry/Spectrum Analysis, Mass; Play; Point Mutation; Post-Transcriptional Gene Silencing; Post-Transcriptional Gene Silencings; Posttranscriptional Gene Silencing; Posttranscriptional Gene Silencings; Proteins; Quelling; RNA Expression; RNA Interference; RNA Silencing; RNA Silencings; RNAi; Role; Sequence-Specific Posttranscriptional Gene Silencing; Spectrometry, Mass; Spectroscopy, Mass; Spectrum Analyses, Mass; Spectrum Analysis, Mass; Structure; Sub-Saharan Africa; Subsaharan Africa; Surface Glycoproteins; T. brucei; Transcription; Transcription, Genetic; Trypanosoma; Trypanosoma brucei; Trypanosoma brucei brucei; Trypanosome; Trypanosomiasis, African; Yeasts; body system, allergic/immunologic; bovid; bovine; cDNA Library; cow; cultured cell line; gene product; genome mutation; in vivo; mutant; nagana; organ system, allergic/immunologic; overexpression; protein complex; sleeping sickness; social role; telomere

Project start date: 2007-01-01

Project end date: 2010-12-31

Budget start date: 1-JAN-2010

Budget end date: 31-DEC-2010

5R01AI066095-04 (2010): $273742



Grants awarded to Bibo Li

CHARACTERIZATION OF TRYPANOSOME TELOMERE COMPLEX

Bibo Li
Cleveland State University, Sponsored Programs And Research, Cleveland, Oh 44115

Grant 3R01AI066095-03S1 from Office Of The Director, National Institutes Of Health

Abstract: This award is issued in response to Notice OD-09-060, Recovery Act Administrative Supplements Providing Summer Research Experiences for Students and Science Educators.T. brucei is a parasite that causes sleeping sickness in humans and Nagana in cattle in sub-Saharan Africa. When growing in mammalian host, T. brucei cells regularly switch their major surface glycoprotein, to evade the host immune system - a phenomenon called antigenic variation. These surface glycoproteins are exclusively expressed from one of ~ 20 loci located next to chromosome ends - telomeres. Telomeres in yeasts form a specialized structure that influences transcription of genes located close by. A similar phenomenon has also been observed in T. brucei, and telomeres may play an important role in antigenic variation. The ultimate goal of telomere studies in Trypanosoma brucei is to understand telomere functions in antigenic variation, an essential aspect of T. brucei pathogenesis. The fundamental step would be to identify telomere components and characterize their functions, which is the primary goal of this proposal. Specific Aim 1 To purify tbTRF (a double-stranded telomere DMA binding factor in T. brucei) protein complex, using two approaches 1) Sequential immunoprecipitate pull-down of FLAG-HA-HA tagged tbTRF using anti-FLAG and anti-HA monoclonal antibodies. Proteins co-immunoprecipitated will be identified by mass spectrometry. 2) Yeast 2-hybrid screen using lexA-tbTRF as bait and a T. brucei GAD-fusion cDNA library. Candidates for tbTRF-interaction factors will be first confirmed for their interaction with tbTRF in vivo by co-immunoprecipitation. Positive clones will be characterized for their roles in antigenic variation and telomere functions by examination of phenotypes in knockout or RNAi knockdown cell lines. Specific Aim 2 Select non-lethal interaction-deficient tbTRF mutations in the tbTRFH domain to better characterize tbTRF´s function. Random point mutations or small deletions will be generated in the tbTRFH domain, using PCR cloning. Mutants that lose the interaction with wild-type tbTRF but remain the ability to interact with themselves will be screened using both conventional and reverse 2-hybrid analysis. Cell lines with knock-in or overexpression of these mutant alleles will be characterized for their phenotypes in antigenic variation. The identification of telomere complex components and subsequent characterization of their functions would be a good starting point for studying telomere functions in antigenic variation, an essential aspect of T. brucei pathogenesis

Keywords: Africa South of the Sahara; African Sleeping Sickness; African Trypanosomiasis; Alleles; Allelomorphs; Antigen Variation; Antigenic Variability; Antigenic Variation; Binding; Binding (Molecular Function); Bovine Species; Cattle; Cell Line; Cell Lines, Strains; Cell Surface Glycoproteins; CellLine; Cells; Chromosomes; Cloning; Co-Immunoprecipitations; Complex; Gene Transcription; Genetic Alteration; Genetic Change; Genetic Transcription; Genetic defect; Genetics-Mutagenesis; Goals; Human; Human, General; Hybrids; Immune system; Knock-in; Knock-in Mouse; Knock-out; Knockout; Man (Taxonomy); Man, Modern; Mass Spectrum; Mass Spectrum Analysis; Membrane Glycoproteins; Moab, Clinical Treatment; Molecular Biology, Mutagenesis; Molecular Interaction; Monoclonal Antibodies; Mutagenesis; Mutation; Parasites; Pathogenesis; Phenotype; Photometry/Spectrum Analysis, Mass; Play; Point Mutation; Post-Transcriptional Gene Silencing; Post-Transcriptional Gene Silencings; Posttranscriptional Gene Silencing; Posttranscriptional Gene Silencings; Proteins; Quelling; RNA Expression; RNA Interference; RNA Silencing; RNA Silencings; RNAi; Role; Sequence-Specific Posttranscriptional Gene Silencing; Spectrometry, Mass; Spectroscopy, Mass; Spectrum Analyses, Mass; Spectrum Analysis, Mass; Structure; Sub-Saharan Africa; Subsaharan Africa; Surface Glycoproteins; T. brucei; Transcription; Transcription, Genetic; Trypanosoma; Trypanosoma brucei; Trypanosoma brucei brucei; Trypanosome; Trypanosomiasis, African; Yeasts; body system, allergic/immunologic; bovid; bovine; cDNA Library; cow; cultured cell line; gene product; genome mutation; in vivo; mutant; nagana; organ system, allergic/immunologic; overexpression; protein complex; sleeping sickness; social role; telomere

Project start date: 2009-06-19

Project end date: 2010-09-30

Budget start date: 19-JUN-2009

Budget end date: 30-SEP-2010

3R01AI066095-03S1 (2009): $17665


1R01AI066095-01A2 (2007): $299494